To evaluate PSA levels and kinetic cutoffs to predict positive bone scans for men with non-metastatic castration-resistant prostate cancer (CRPC) from the Shared Equal Access Regional Cancer ...

A bone scan is a nuclear imaging test that can help tell you if you have certain types of bone disease. You may get this kind of scan to see if cancer has spread to your bones or to view how well ...

A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies. Laura is an Assistant Editor for The Scientist. She has a ...

Patients with mCRPC prostate cancer have an elevated risk of fractures due to bone metastases and use of androgen receptor pathway inhibitors (ARPI).

For patients with metachronous low burden mCSPC on conventional imaging being recommended for systemic therapy, 51% responded ...

A 66-year-old male patient underwent surgery for prostate cancer 4 years ago. His initial prostate-specific antigen (PSA) ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Prostate cancer frequently metastasises to the bone due to the expression of androgen receptors, which are targeted by therapies to inhibit metastasis. Melanoma can spread widely through the ...

One test could have prevented terminal prostate cancer, says patient - Research has shown that the use of the PSA test varies ...

PSMA PET/CT trial will scan up to 1000 men in the UKA new kind of scan that could be key to improving the treatment of high-risk prostate cancer is ...

Further tests, such as CT scans and bone scans, may be performed to determine whether prostate cancer has spread. Management strategies for prostate cancer should be guided the severity of the ...

A new study investigates the utility of whole-body magnetic resonance imaging for detecting lymph and bone metastases in those with high-risk prostate cancer. Visit us on Facebook. Opens in a new ...